Arkolith/Insider Trading/ARMP/Form 4

Innoviva Strategic Opportunities LLC

Director, 10% OwnerArmata Pharmaceuticals, Inc. (ARMP) · full profile →Form 4 · filed Jan 28, 2021
Net Buying
Open-Market Buys
$6.1M
Open-Market Sells
$0
Net Open-Market Flow
$6.1M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2021Buy(P)1.9M$3.25$6.1M1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2021Buy(P)1.9M$3.25$6.1M1.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-003595) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML